Business
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Total revenues of €174.7 million in line with guidance, including €157.9 million in product sales Strong year-end cash position of €109.7 million, with enhanced financial flexibility following successful debt refinancing and a 21% reduction in operating cash burn2026 to be a potentially transformational year with Phase 3 Lyme disease data expected in the first half of the year Lyon (France), March 18, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today repor
About this update from Valneva Se
[{"type":"image","alt":"VALNEVA","displaySize":"","headline":null,"caption":"VALNEVA","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":44,"url":"https://media.zenfs.com/en/globenewswire.com/29df7eb71c048b91fe66a95a1cd8b1d6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9l2h5dKc1PlSY26lXUAWsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTYyO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/29df7eb71c048b91fe66a95a1cd8b1d6","width":300,"height":44}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Total revenues of €174.7 million in line with guidance, including €157.9 million in product sales ","length":97,"tagName":"p"}]},{"val":[{"type":"text","content":"Strong year-end cash position of €109.7 million, with enhanced financial flexibility following successful debt refinancing and a 21% reduction in operating cash burn","length":165,"tagName":"p"}]},{"val":[{"type":"text","content":"2026 to be a potentially transformational year with Phase 3 Lyme disease data expected in the first half of the year","length":116,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":378,"olType":false},{"type":"text","content":"Lyon (France), March 18, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported its audited consolidated financial results for the year ended December 31, 2025, provided corporate updates and confirmed its financial guidance for 20261. The Company also announced the filing of its annual report on Form 20-F and Universal registration document (URD) for the financial year ended December 31, 2025 with the U.S. Securities and Exchange Commission (SEC) and the French financial market authority (Autorité des marchés financiers or AMF), respectively. The full-year 2025 consolidated financial results are available on the Company’s website (Financial Reports – Valneva) 2.","length":715,"tagName":"p"},{"type":"text","content":"Valneva will provide a live webcast of its full-year 2025 results conference call beginning at 3 p.m. CET/10 a.m. EDT today. This webcast will also be available on the Company’s website. Please refer to this link: https://edge.media-server.com/mmc/p/qj2g7e52","length":259,"tagName":"p"},{"type":"text","content":"2025 Financial Performance","length":26,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Tot...